Inmune Bio, Inc.
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| INMUNE BIO INC. | |
| /s/ David J. Moss | |
| Dated: March 30, 2026 | David J. Moss |
|---|---|
| Chief Executive Officer | |
| (Principal Executive Officer) | |
| /s/ Cory Ellspermann | |
| Dated: March 30, 2026 | Cory Ellspermann |
| Chief Financial Officer | |
| (Principal Financial and Accounting Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ David J. Moss | President, Chief Executive Officer, Treasurer, Secretary and Director | March 30, 2026 |
| David J. Moss | (Principal Executive Officer) | |
| /s/ Cory Ellspermann | Chief Financial Officer | March 30, 2026 |
| Cory Ellspermann | (Principal Financial and Accounting Officer) | |
| /s/ Timothy Schroeder | Director | March 30, 2026 |
| Timothy Schroeder | ||
| /s/ J. Kelly Ganjei | Director | March 30, 2026 |
| J. Kelly Ganjei | ||
| /s/ Scott Juda, JD | Director | March 30, 2026 |
| Scott Juda, JD | ||
| /s/ Marcia Allen | Director | March 30, 2026 |
| Marcia Allen | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
| AUDITED FINANCIAL STATEMENTS: | |
|---|---|
| REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID Number 199) | F-2 |
| REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNING FIRM (PCAOB ID Number 688) | F-3 |
| CONSOLIDATED BALANCE SHEETS AS OF DECEMBER 31, 2025 AND 2024 | F-4 |
| CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024 | F-5 |
| CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024 | F-6 |
| CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024 | F-7 |
| NOTES TO CONSOLIDATED FINANCIAL STATEMENTS | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.